Full text is available at the source.
Abstract
Reboxetine may improve social functioning significantly more than fluoxetine in the treatment of major depression.
- Numerous studies have compared the efficacy of selective serotonin reuptake inhibitors (SSRIs) and noradrenaline reuptake inhibitors (NRIs) with varied selectivity.
- Most studies indicate no significant differences in response rates or subtype responsivity between SSRIs and NRIs.
- Some studies suggest NRIs could be superior to SSRIs in addressing retardation symptoms.
- SSRIs may be more effective than NRIs for anxiety symptoms.
- NRIs might be more effective than SSRIs in cases of severe depression.
- Reboxetine has been shown to be at least as effective as imipramine, desipramine, and fluoxetine.
Simplified